UNLOCKING “SILENT†GENES VIA COMBINE CULTURE–AN ALTERNATIVE GATEWAY TO NATURAL PRODUCTS DISCOVERY

Authors

  • Izzatul Hidayah Azizan School of Chemical Sciences & Food Technology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
  • Jalifah Latip School of Chemical Sciences & Food Technology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
  • Shotaro Hoshino Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
  • Ikuro Abe Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan

DOI:

https://doi.org/10.11113/jt.v77.5978

Keywords:

Streptomyces, Tsukamurella, combined culture

Abstract

Streptomyces sp. has been known to produce antibiotics and other bioactive natural products. However, the production of these secondary metabolites depends on the culture conditions, where in most cases the secondary-metabolite genes are not expressed in fermentation culture. Recently, a novel fermentation method known as combined-culture has been introduced to unlock these “silent†genes, hence induces the production of cryptic metabolites. We report herein, our preliminary work on combined-culture using two soil-borne bacterial strains; Streptomyces and Tsukamurella. From the results, it is shown that the presence of Tsukamurella, a mycolic acid-containing bacterium induces the production of new metabolites in Streptomyces. Moreover, the production of compounds associated with Streptomyces was enhanced via combination-culture as compared to culture of Streptomyces strain alone. These findings may promote the feasibility of combined-culture in unlocking the “silent†genes of microorganisms which could lead to the discovery of novel metabolites.

References

Arasu, M.V., Duraipandiyan, V. and Ignacimuthu, S. 2013. Antibacterial and Antifungal Activities of Polyketide Metabolite from Marine Streptomyces sp. AP-123 and its Cytotoxic Effect. Chemosphere. 90(2): 479-87.

Yokomizo, K., Miyamoto, Y., Nagao, K., Kumagae, E., Habib, E.S., Suzuki, K., Harada, S. and Uyeda, M. 1998. Fattiviracin A1, A Novel Antiviral Agent Produced by Streptomyces microflavus Strain No. 2445. II. Biological Properties. The Journal Antibiotics. 51(11): 1035-1039.

Schleissner, C., Perez, M., Losada, A., Rodriguez, P., Crespo, C., Zuniga, P., Fernandez, R., Reyes, F. de la Calle, F. 2011. Antitumor Actinopyranose Produces by Streptomyces albus POR-04-15-053 Isolated from Marine Sediment. Journal of Natural Products. 74(7): 1590-1596.

Cioni, J.P., Doroghazi, J.R., Ju, K.-S., Yu, X., Evans, B.S., Lee, J. and Metcalf, W.W. 2014. Cynohydrin Phosphonate Natural Products from Streptomyces regensis. Journal of Natural Products. 77(2): 243-249.

De Lima Procopio, R. E., da Silva, I. R., Martins, M. K., de Azevedo, J. L. and de Araujo, J. M. 2012. Antibiotic produced by Streptomyces. Brazilian Journal of Infectious Diseasess. 16(5): 466-471.

Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H. 1987. FK-506, A Novel Immunosuppressant Isolated from a Streptomyces. II. Immunosuppressive Effect of FK-506 in vitro. The Journal of Antibiotics. 40(9): 1256-1265.

Waksman, S. A. 1953. Streptomycin: Background, Isolation, Properties and Utilization. Science. 118: 259-266.

Scherlach, K. and Hertweck, C. 2009. Triggering Cryptic Natural Product Biosynthesis in Microorganisms. Organic and Biomolecular Chemistry. 7(9): 1753-1760.

Hosaka, T., Ohnishi-Kameyama, M., Muramatsu, H., Murakami, K., Tsurumi, Y., Kodani, S., Yoshida, M., Fujie, A. and Ochi, K. 2009. Antibacterial Discovery in Actinomycetes Strains with Mutations in RNA Polymerase or Ribosomal Protein S12. Nature Biotechnology. 27(5): 462-464.

Onaka, H., Tabata, H., Igarashi, Y., Sato, Y. and Furumai, T. 2001. Goadsporin, A Chemical Substance Which Promotes Secondary Metabolism and Morphogenesis in Streptomycetes. I. Purification and Characterization. The Journal of Antibiotics. (Tokyo). 54(12): 1036-1044.

Onaka, H., Taniguchi, S., Ikeda, H., Igarashi, Y. and Furumai, T. 2003. pTOYAMAcos, pTYM18, and pTYM19, actinomycete-Eschericia coli Integrating Vectors for Heterologous Gene Expression. The Journal of Antibiotics. (Tokyo). 56(11): 950-956.

Cueto, M., Jensen, P.R., Kauffman, C., Fenical, W., Lobkovsky, E. and Clardy, J. 2001. Pestalone, A New Antibiotic Produced by a Marine Fungus in Response to Bacterial Challenge. Journal of Natural Products. 64(11): 1444-1446.

Schroeckh, V., Scherlach, K., Nutzmann, H.W., Shelest, E., Schmidt-Heck, W., Schuemann, J. Martin, K., Hertweck, C. and and Brakhage, A.A. 2009. Intimate Bacterial-fungal Interaction Triggers Biosynthesis of Archetypal Polyketides in Aspergillus nidulans. Proceedings of The National Academy of Sciences. U. S. A. 106(34): 14558-14563.

Onaka, H., Mori, Y., Igarashi, Y. and Furumai, T. 2011. Mycolic Acid Containing Bacteria Induce Natural Product Biosynthesis in Streptomyces species. Applied and Environmental Microbiology. 77(2): 400-406.

Hoshino, T., Kojima, Y., Hayashi, T., Uchiyama, T. and Kaneko, K. 1993. A New Metabolite of Tryptophan, Chromopyrrolic Acid, Produced by Chromobacterium violaceum. Bioscience Biotechnology and Biochemistry. 57(5): 775-781.

Hoshino, S., Zhang, L., Awakawa, T., Wakimoto, T., Onaka, H. and Abe, I. 2015. Arcyriaflavin E, A New Cytotoxic Indolocarbazole Alkaloid Isolated by Combined-Culture Of Mycolic Acid-Containing Bacteria and Streptomyces cinnamoneus NBRC 13823. The Journal of Antibiotics. 68: 342-344.

Downloads

Published

2015-10-28

How to Cite

UNLOCKING “SILENT” GENES VIA COMBINE CULTURE–AN ALTERNATIVE GATEWAY TO NATURAL PRODUCTS DISCOVERY. (2015). Jurnal Teknologi, 77(2). https://doi.org/10.11113/jt.v77.5978